Statistics for Eliem Therapeutics, (id:6862 ELYM)

Valuation metrics

Market cap

342.68M

Enterprise value

118.97M

Trailing P/E (ttm)

-2.35

Forward P/E

-9.83

PEG ratio

-9.83

Price/Sales (ttm)

Price/Book (mrq)

1.54

Enterprise Value/Revenue

Enterprise Value/EBITDA

-2.92

Overview

Shares outstanding

67.06M

Float

26.24M

Shares short

1.15M

% Held by insiders

0.10%

% Held by institutions

0.78%

Average volume (10 days)

288.93K

Average volume (90 days)

Price summary

52-Week low

2.35

52-Week high

11.55

52-Week change

15.08%

Beta

-0.38

50-Day moving average

6.46

200-Day moving average

5.57

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

0.00%

Operational effectiveness

Return on assets

-24.54%

Return on equity

-38.35%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

0.00

Net income to common (ttm)

-64,195,000.00

Diluted EPS (ttm)

-2.22

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

223.14M

Total cash per share (mrq)

3.33

Total debt (mrq)

100.00K

Total Debt/Equity (mrq)

0.04

Current ratio (mrq)

6.04K%

Book value per share (mrq)

3.33

Cash flow

Cash flow statement

57.00K

Levered free cash flow (LFCF)

-29,909,876.00